These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7083244)

  • 21. Baker's antifol in combination with 5-fluorouracil and methyl-CCNU in the treatment of metastatic colorectal cancer: a Southwest Oncology Group Study (Protocol 7764).
    Shaw MT; Bonnet JD; Wilson H; Heilbrun LK
    Cancer Treat Rep; 1980; 64(2-3):247-50. PubMed ID: 7407758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
    Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
    Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase II evaluation of diglycoaldehyde, VP-16-213, and the combination of methyl-CCNU and beta-2'-deoxythioguanosine in previously treated patients with colorectal cancer: an Eastern Cooperative Oncology Group study (EST-1275).
    Douglass HO; Lavin PT; Evans JT; Mittelman A; Carbone PP
    Cancer Treat Rep; 1979 Aug; 63(8):1355-7. PubMed ID: 476709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iv methyl-CCNU and ftorafur with or without methanol-extracted residue of BCG for metastatic adenocarcinoma of the colon.
    Diggs CH; Wiernik PH; Smyth AC
    Cancer Treat Rep; 1977 Nov; 61(8):1581-3. PubMed ID: 336200
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea adjuvant therapy on the immune response of patients with malignant melanoma.
    Berd D; Wilson EJ; Bellet RE; Mastrangelo MJ
    Cancer Res; 1979 Nov; 39(11):4472-6. PubMed ID: 387215
    [No Abstract]   [Full Text] [Related]  

  • 26. Phase II study of an aziridinylbenzoquinone (AZQ) in disseminated malignant melanoma.
    Creagan ET; Schutt AJ; Ahmann DL; Green SJ
    Cancer Treat Rep; 1982 Dec; 66(12):2089-90. PubMed ID: 7139650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II study of diglycoaldehyde in malignant melanomas and soft tissue sarcomas.
    Vosika GJ; Briscoe K; Carey RW; O'Donnell JF; Perry MC; Budman D; Richards F; Coleman M
    Cancer Treat Rep; 1981; 65(9-10):823-5. PubMed ID: 7273013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Phase II trial of vinorelbine tartrate in patients with disseminated malignant melanoma and one prior systemic therapy: a Southwest Oncology Group study.
    Whitehead RP; Moon J; McCachren SS; Hersh EM; Samlowski WE; Beck JT; Tchekmedyian NS; Sondak VK;
    Cancer; 2004 Apr; 100(8):1699-704. PubMed ID: 15073859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination with 5-fluorouracil, methyl-CCNU and beta-2-deoxythioguanosine in advanced colo-rectal adenocarcinoma.
    Cedermark BJ; Kaufman JH; Douglass HO; Mittelman A
    Clin Oncol; 1977 Mar; 3(1):27-31. PubMed ID: 862274
    [No Abstract]   [Full Text] [Related]  

  • 30. Phase II study of dibromodulcitol in colorectal, kidney, and other carcinomas.
    Mischler NE; Tormey DC; Klotz J; Borden EC; Ramirez G; Banerjee TK; Carr RM; Zaentz SD; Graf J
    Cancer Clin Trials; 1981; 4(4):407-10. PubMed ID: 7318122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase I trial of combination methotrexate and methyl-CCNU in patients with advanced neoplastic diseases.
    Lehane DE; Lane M; Tranum B; Costanzi J; Padilla F
    Cancer Treat Rep; 1977 Aug; 61(5):889-91. PubMed ID: 329982
    [No Abstract]   [Full Text] [Related]  

  • 32. Phase II trial of 4'-epi-doxorubicin in patients with advanced malignant melanoma.
    Berman E; Casper ES; Howard J; Wittes RE
    Cancer Treat Rep; 1984 Apr; 68(4):679-80. PubMed ID: 6585272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The combination methyl-CCNU, vincristine, 5-fluorouracil and streptozotocin in the treatment of advanced colo-rectal adenocarcinoma].
    Togni P; Sessa C; Varini M; Cavalli F
    Schweiz Med Wochenschr; 1982 Jun; 112(26):930-3. PubMed ID: 6214002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methyl-CCNU for patients with previously treated metastatic neuroblastoma--a phase II study.
    Evans AE; Bernstein I; Finklestein J; Klemperer M; Leikin S; Weiner JM; Hammond GD
    Cancer Treat Rep; 1977; 61(1):83-5. PubMed ID: 324623
    [No Abstract]   [Full Text] [Related]  

  • 35. Phase II evaluation of dibromodulcitol and actinomycin D, hydroxyurea, and cyclophosphamide in previously untreated patients with malignant melanoma.
    Amato DA; Bruckner H; Guerry D; Ash A; Falkson G; Borden EC; Creech RH; Savlov ED; Cunningham TJ
    Invest New Drugs; 1987; 5(3):293-7. PubMed ID: 3667165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of an intermittent schedule of mitolactol in advanced non-small cell lung cancer.
    Eagan RT; Frytak S; Nichols WC; Ingle JN; Creagan ET; Kvols LK; Coles DT
    Cancer Treat Rep; 1981; 65(11-12):1099-1101. PubMed ID: 6271397
    [No Abstract]   [Full Text] [Related]  

  • 37. Phase II study of methyl-CCNU in the treatment of advanced pancreatic carcinoma.
    Moertel CG; Douglass HO; Hanley J; Carbone PP
    Cancer Treat Rep; 1976 Nov; 60(11):1659-61. PubMed ID: 1035508
    [No Abstract]   [Full Text] [Related]  

  • 38. Nitrosoureas in the management of disseminated malignant melanoma.
    Ahmann DL
    Cancer Treat Rep; 1976 Jun; 60(6):747-51. PubMed ID: 782696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination chemotherapy in patients with advanced colorectal carcinoma previously treated with 5-FU.
    Windschitl HE; Krook JE; Everson LK; Cullinan SA; Scott M
    Cancer Treat Rep; 1982 Dec; 66(12):2093-4. PubMed ID: 7139652
    [No Abstract]   [Full Text] [Related]  

  • 40. Phase II study of dibromodulcitol and BCNU in metastatic malignant melanoma.
    Clamon G; Sinkey C; Jochimsen P
    Am J Clin Oncol; 1985 Jun; 8(3):244-6. PubMed ID: 4050743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.